RAS is pivotal for macropinocytosis formation [185], yet it also inhibits lipid peroxidation through multiple pathways such as NFE2L2 [104] and fatty acid synthase (FASN) [186], suggesting that targeting RAS may have varied effects on specific cancer cells. The gene discussed is FASN; the disease is cancer.